Maipl Therapeutics Reports Preclinical Progress for MA-4604, a Novel Oral Non-Hormonal Treatment of Endometriosis

B SCARSDALE, N.Y., May 14, 2026 /PRNewswire/ — Maipl Therapeutics today highlighted continued preclinical progress for MA-4604, its lead investigational therapy for endometriosis. MA-4604 is a…
posteditor
posteditor
Articles: 17424

Other News